Commercialization Support Services

Accelerating the Development of Innovative Healthtech Solutions

Commercialization Support Services; images of healthtech and boxes being checked

Commercialization Infrastructure Partner

VentureWell is committed to solving emerging healthcare challenges by supporting innovative technologies and nurturing entrepreneurial ecosystems. We understand that ideas don’t magically transform into success stories. Vision must be accompanied by action, and groundbreaking technologies must navigate a path of technical, regulatory, and funding hurdles to be viable. It takes a community to build successful ventures. In the spirit of our core mission, VentureWell has leveraged its experience and network to provide a rigorous process to identify, assess, select, and contract with vendors and professional services consultants to support the commercialization of diagnostics and medtech. We have brought all of this together under the Commercialization Support Services Center. By bringing together proven industry experts during critical stages of technology development, we help de-risk these technologies and accelerate product time to market.

An example of the Commercialization Support Services in action is our support for the National Institutes of Health’s (NIH) RADx® (Rapid Acceleration of Diagnostics for COVID-19 Testing) initiative. In helping our nation respond to a public health crisis, VentureWell provided infrastructure support to the energized community of RADx® innovators to identify, develop, and launch crucial COVID-19 testing solutions. Through this process, we contracted with hundreds of consultants and vendors to tackle challenges associated with rapid diagnostics development. A process that would normally take years was shortened to months. The end result has led to over 7 billion at-home COVID tests being produced and over a dozen Emergency Use Authorizations (EUA) being issued by the U.S. Food and Drug Administration (FDA). And our involvement in newer NIH RADx®-type programs is catalyzing the commercialization of other point of care diagnostics for HIV, Hepatitis C, and Mpox detection. Additionally, we are partnering with NIH on other initiatives for improving maternal health, in multi-cancer screening, and in technologies for treating or diagnosing disorders involving the nervous system (NIH Blueprint Neuro MedTech). The framework we have established within the Commercialization Center will continue to have lasting global impact for improving public health and well-being.

How To Engage

Are you a professional services provider interested in engaging with VentureWell’s Commercialization Center? Our current roster consists of consultants and vendors in these content areas (non-exhaustive list):

  • Accounting
  • Bench and Safety Testing
  • Business Development
  • Human Resource Staffing and Recruiting
  • Engineering Design/Prototyping
  • Legal—General (IP, Contracts, Company Formation)
  • Legal—Regulatory (EUA Submission, FDA 510k)
  • Logistics and Distribution Advising
  • Manufacturing Design and Development
  • Market/User Research
  • Quality Management System Advising
  • Regulatory Advising
  • Regulatory Lab Testing

If you are interested in providing professional services consulting or vendor services, please go to VentureWell’s Procurement Portal, look through our current Blueprint MedTech Opportunities, or contact with any questions.

By continuing to use the site, you agree to the use of cookies. Read More